CPhI Japan

Activities: Recruitment Ingredients Regulatory Digital Pharmaceutical Logistics

Trending Articles

  1. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  2. Manufacturing Chemist Stand Side with Piramal Pharma Solutions We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  3. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  4. One in four European pharma companies at risk of regulatory breaches according to NSF research The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten
  5. IWK introduces machine to produce 100% cardboard blister packaging CABLIblue 870 features innovative “card-to-card” technology for recyclable, fiber-based blisters

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Finance

Deprecated Yen attracting renewed international interest in Japanese pharma

Half of all exhibitors at CPHI Japan are international as business links strengthen with Switzerland, Korea, USA and the UK
Manufacturing

Japan produces highest quality APIs, CPhI data says

Several COVID vaccines are approaching commercial launch in Japan, coinciding with an ongoing biosimilars boom
Research & Development

CPhI Japan: Internationalisation reaches new heights

Innovation in the country, driven by structural and and regulatory changes, has promoted both inbound and outbound collaboration
Finance

Pricing system reform and generics trend apparent at CPhI Japan 2018

After recent changes in Japan, which is known to be an innovative drug market, an increase in international generic API companies and suppliers has been reported at next month’s CPhI Japan 2018
Media

CPhI Japan predicts a transformative year for Japanese pharma

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma, as the market evolves towards growth in generics, biosimilars and increased internationalisation
Pharmaceutical

CPhI Japan to explore changes in generics and OTC

Growing market for generics and liberalisation of OTC medicines driving demand at CPhI Japan
Manufacturing

CPhI Japan

20 - 22 April 2016, Exhibition, Tokyo, Japan
Subscribe now